TACR1 and hematoma: In our previous study, we demonstrated that Aprepitant (chemical name: 3- [ [(2S,3R)-2- [(1R)-1- [3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,4-dihydro-1,2,4-triazol-5-one), a specific inhibitor of NK1R, reduces hematoma volume and thus improves neurological deficits in ICH mice [20].